Max Healthcare Institute shares fall 2.06% in early trade

Shares of Max Healthcare Institute Limited declined by 2.06% to Rs 1,196.20 in early trade. At 09:28 am, the stock reflected a negative trend on the exchanges.

On the financial front, the consolidated quarterly revenue for Max Healthcare Institute has shown consistent growth. The revenue for the quarter-ending June 2024 was Rs 1,542.95 Crore, which increased to Rs 1,707.46 Crore for September 2024, Rs 1,868.31 Crore for December 2024, and further to Rs 1,909.74 Crore for March 2025. The latest quarter-ending June 2025 saw revenue reaching Rs 2,027.57 Crore.

Net profit also experienced fluctuations across the quarters. It stood at Rs 236.27 Crore for June 2024, increased to Rs 281.81 Crore in September 2024, then slightly decreased to Rs 238.80 Crore in December 2024, before rising again to Rs 319.00 Crore in March 2025. For the quarter-ending June 2025, the net profit was Rs 307.97 Crore.

Earnings per share (EPS) followed a similar trend, with values of Rs 2.43 for June 2024, Rs 2.90 for September 2024, Rs 2.46 for December 2024, Rs 3.28 for March 2025, and Rs 3.17 for June 2025.

The consolidated yearly financials reveal a strong growth trajectory. Revenue increased from Rs 2,504.67 Crore in 2021 to Rs 3,931.46 Crore in 2022, Rs 4,562.60 Crore in 2023, Rs 5,406.02 Crore in 2024, and reached Rs 7,028.46 Crore in 2025.

Net profit has also shown significant improvement, turning from a loss of Rs -114.50 Crore in 2021 to a profit of Rs 605.05 Crore in 2022, Rs 1,103.51 Crore in 2023, Rs 1,057.64 Crore in 2024, and Rs 1,075.88 Crore in 2025.

Similarly, the Earnings per Share (EPS) has grown from Rs -1.59 in 2021 to Rs 6.25 in 2022, Rs 11.38 in 2023, Rs 10.89 in 2024, and Rs 11.07 in 2025.

The annual income statement shows consistent growth in sales, from Rs 2,504 Crore in March 2021 to Rs 7,028 Crore in March 2025. Total income also increased significantly, from Rs 2,619 Crore in March 2021 to Rs 7,184 Crore in March 2025. The company's total expenditure rose from Rs 2,508 Crore in March 2021 to Rs 5,612 Crore in March 2025. Consequently, the Earnings Before Interest and Taxes (EBIT) increased from Rs 110 Crore in March 2021 to Rs 1,571 Crore in March 2025. Net profit has also seen a substantial rise, from a loss of Rs -114 Crore in March 2021 to a profit of Rs 1,075 Crore in March 2025.
The company has announced several corporate actions. The transcript of the earnings call held on August 14, 2025, was announced under Regulation 30 (LODR). Additionally, an agreement was made to lease for establishing a 130-bedded built-to-suit hospital at Dehradun, Uttarakhand. A presentation on earnings update for the quarter ended June 30, 2025, was also released.

The company announced a final dividend of Rs 1.50 per share (15%) with an effective date of July 4, 2025. Prior to this, a final dividend of Rs 1.50 per share was announced on May 22, 2024, with an effective date of August 23, 2024.

The company’s cash flow from operating activities has generally increased over the years, from Rs 117 Crore in March 2021 to Rs 1,459 Crore in March 2025. However, net cash flow showed fluctuations, with a net outflow of Rs -318 Crore in March 2025.

The balance sheet shows that total assets have grown from Rs 8,544 Crore in March 2021 to Rs 15,214 Crore in March 2025, reflecting overall growth and expansion. Fixed assets have nearly doubled from Rs 4,108 Crore to Rs 8,922 Crore during the same period.

Key financial ratios for Max Healthcare Institute as of March 2025 include a basic EPS of Rs 11.07 and a diluted EPS of Rs 11.01. The book value per share (excluding revaluation reserve) stood at Rs 96.50. The company’s dividend per share was Rs 1.50, with a face value of Rs 10. The debt to equity ratio was 0.27, and the interest coverage ratio was 12.15.

The stock is part of the NIFTY MIDCAP 150 index.

With the stock currently trading at Rs 1,196.20, Max Healthcare Institute Limited experienced a decline of 2.06% in early trading.